Champions Oncology Names Angela Davies, M.D., Chief Medical Officer

Published January 10, 2014

Champions Oncology Names Angela Davies, M.D., Chief Medical Officer

Filed under: drug treatment programs in maryland

Previously, she was Chief Medical Officer of OSI Pharmaceuticals where she led the clinical development program for Tarceva® (erlotinib), as well as other pipeline products, until the company's acquisition by Astellas Pharma. … of expertise will …
Read more on Sacramento Bee

Auxilium Pharmaceuticals Presents Interim Data on XIAFLEX® for the …

Filed under: drug treatment programs in maryland

This open-label Phase 4 study is evaluating 51 patients who had recurrence of a contracture (an increase of >20 degrees as well as a palpable cord) in a joint that had been previously effectively treated with XIAFLEX (resulting in contracture of <5 …
Read more on Sacramento Bee

Portage acquires majority interest in Biohaven Pharmaceutical Holding …

Filed under: drug treatment programs in maryland

Biohaven has a worldwide license from Yale University to use intellectual property relating to the use of certain glutamate modulating agents in the treatment of neuropsychiatric disorders. The company's first drug candidate … Team members have …
Read more on Sacramento Bee